Update on neuromuscular pharmacology

Current Opinion in Anaesthesiology

Volumn 14, Issue 4, 2001, Pages 399-404

  Meistelman, Claude ^a,b  

^a School of Medicine   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; NEUROMUSCULAR BLOCKING AGENT; ORG 9488; RAPACURONIUM BROMIDE; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG; VECURONIUM;

ANAPHYLAXIS; BURN; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; HUMAN; INTUBATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; PARALYSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0034942049     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200108000-00004     Document Type: Review

References (39)

1. Nicotinic receptors at the amino acid level
2. The mechanism of pancuronium potentiation of mivacurium block: Use of the isolated-arm technique
3. Requirements for muscle relaxants during radical retropubic prostatectomy
4. Tracheal intubation in ambulatory surgery patients: Using remifentanil and propofol without muscle relaxants
5. -1
6. Remifentanil and propofol without muscle relaxants or with different doses of rocuronium for tracheal intubation in outpatient anaesthesia
7. The onset time of rocuronium is slowed by esmolol and accelerated by ephedrine
8. Temporal relation between acoustic and force responses at the adductor pollicis during nondepolarizing neuromuscular block
9. A method to measure elicited contraction of laryngeal adductor muscles during anesthesia
10. Surface vs intramuscular laryngeal electromyography
11. Comparison of succinylcholine with two doses of rocuronium using a new method of monitoring neuromuscular block at the laryngeal muscles by surface laryngeal electromyography
12. Sensitivity to atracurium in the lateral abdominal muscles
13. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers
14. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: Pharyngeal videoradiography and simultaneous manometry after atracurium
15. Structure: Action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat
16. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant: A comparison with succinylcholine
17. Dose-response and onset/offset characteristics of rapacuronium
18. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans
19. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine
20. Onset/offset characteristics and intubating conditions of rapacuronium: A comparison with rocuronium
21. ORG 9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans
22. Reversal of rapacuronium block during propofol versus sevoflurane anesthesia
23. Spontaneous recovery profile of rapacuronium during desflurane, sevoflurane, or propofol anesthesia for outpatient laparoscopy
24. Rapacuronium recovery characteristics and infusion requirements during inhalation versus propofol-based anaesthesia
25. -1
26. Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by borus followed by infusion
27. Rapacuronium and bronchospasm
28. Residual curarization in the recovery room after vecuronium
29. Postoperative residual curarization and evidence-based anaesthesia
30. A comparison of antagonism of rocuronium-induced neuromuscular blockade during sevoflurane and isoflurane anaesthesia
31. Vecuronium-dose response and maintenance requirements in patients with myasthenia gravis
32. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients
33. Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy
34. Succinylcholine-associated postoperative myalgia
35. Thermal injury induces greater resistance to d-tubocurarine in local rather than in distant muscles in the rat
36. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: The value of morphine for the detection of IgE antibodies in allergic subjects
37. Weal and flare responses to intradermal rocuronium and cisatracurium in humans
38. Rocuronium anaphylaxis and multiple neuromuscular blocking drug sensitivities
39. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: A report including 3 cases